C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,764 | -25,129 | -104,994 | -84,508 | -52,342 |
| Depreciation Amortization | -579 | -685 | -783 | -348 | -293 |
| Accounts receivable | 1,067 | -482 | 701 | -3,440 | 901 |
| Accounts payable and accrued liabilities | 263 | -85 | -468 | 4 | 889 |
| Other Working Capital | 9,181 | -8,272 | -29,282 | -22,601 | -6,571 |
| Other Operating Activity | 7,314 | 4,709 | 36,132 | 34,344 | 12,074 |
| Operating Cash Flow | $-31,518 | $-29,944 | $-98,694 | $-76,549 | $-45,342 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -111,641 | -40,812 | -227,074 | -94,003 | -47,320 |
| PPE Investments | -101 | -64 | -607 | -596 | -185 |
| Sale Of Investment | 113,080 | 57,029 | 219,080 | 166,731 | 115,551 |
| Investing Cash Flow | $1,338 | $16,153 | $-8,601 | $72,132 | $68,046 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 34,331 | 606 | 126,318 | 7,633 | N/A |
| Common Stock Repurchased | -200 | -200 | -193 | -179 | -155 |
| Other Financing Activity | 56 | 56 | 274 | 273 | 109 |
| Financing Cash Flow | $34,187 | $462 | $126,399 | $7,727 | $-46 |
| Beginning Cash Position | 78,046 | 78,046 | 58,942 | 58,942 | 58,942 |
| End Cash Position | 82,053 | 64,717 | 78,046 | 62,252 | 81,600 |
| Net Cash Flow | $4,007 | $-13,329 | $19,104 | $3,310 | $22,658 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,518 | -29,944 | -98,694 | -76,549 | -45,342 |
| Capital Expenditure | -101 | -64 | -607 | -596 | -185 |
| Free Cash Flow | -31,619 | -30,008 | -99,301 | -77,145 | -45,527 |